vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and LESAKA TECHNOLOGIES INC (LSAK). Click either name above to swap in a different company.

Doximity, Inc. is the larger business by last-quarter revenue ($185.1M vs $178.7M, roughly 1.0× LESAKA TECHNOLOGIES INC). Doximity, Inc. runs the higher net margin — 33.3% vs 2.0%, a 31.2% gap on every dollar of revenue. On growth, Doximity, Inc. posted the faster year-over-year revenue change (9.8% vs 1.4%). Over the past eight quarters, Doximity, Inc.'s revenue compounded faster (25.2% CAGR vs 13.7%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

DOCS vs LSAK — Head-to-Head

Bigger by revenue
DOCS
DOCS
1.0× larger
DOCS
$185.1M
$178.7M
LSAK
Growing faster (revenue YoY)
DOCS
DOCS
+8.3% gap
DOCS
9.8%
1.4%
LSAK
Higher net margin
DOCS
DOCS
31.2% more per $
DOCS
33.3%
2.0%
LSAK
Faster 2-yr revenue CAGR
DOCS
DOCS
Annualised
DOCS
25.2%
13.7%
LSAK

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
DOCS
DOCS
LSAK
LSAK
Revenue
$185.1M
$178.7M
Net Profit
$61.6M
$3.6M
Gross Margin
89.9%
31.4%
Operating Margin
38.9%
1.2%
Net Margin
33.3%
2.0%
Revenue YoY
9.8%
1.4%
Net Profit YoY
-18.1%
111.2%
EPS (diluted)
$0.31
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCS
DOCS
LSAK
LSAK
Q4 25
$185.1M
$178.7M
Q3 25
$168.5M
$171.4M
Q2 25
$145.9M
$168.5M
Q1 25
$138.3M
$161.4M
Q4 24
$168.6M
$176.2M
Q3 24
$136.8M
$153.6M
Q2 24
$126.7M
$146.0M
Q1 24
$118.1M
$138.2M
Net Profit
DOCS
DOCS
LSAK
LSAK
Q4 25
$61.6M
$3.6M
Q3 25
$62.1M
$-4.3M
Q2 25
$53.3M
$-28.4M
Q1 25
$62.5M
$-22.1M
Q4 24
$75.2M
$-32.5M
Q3 24
$44.2M
$-4.5M
Q2 24
$41.4M
$-5.0M
Q1 24
$40.6M
$-4.0M
Gross Margin
DOCS
DOCS
LSAK
LSAK
Q4 25
89.9%
31.4%
Q3 25
90.3%
30.9%
Q2 25
89.2%
28.9%
Q1 25
89.5%
27.5%
Q4 24
91.6%
25.7%
Q3 24
90.0%
22.6%
Q2 24
89.3%
22.6%
Q1 24
89.4%
22.0%
Operating Margin
DOCS
DOCS
LSAK
LSAK
Q4 25
38.9%
1.2%
Q3 25
37.8%
0.2%
Q2 25
37.4%
-16.7%
Q1 25
35.2%
0.4%
Q4 24
47.4%
0.3%
Q3 24
38.8%
-0.0%
Q2 24
36.4%
0.2%
Q1 24
35.5%
0.6%
Net Margin
DOCS
DOCS
LSAK
LSAK
Q4 25
33.3%
2.0%
Q3 25
36.8%
-2.5%
Q2 25
36.5%
-16.9%
Q1 25
45.2%
-13.7%
Q4 24
44.6%
-18.4%
Q3 24
32.3%
-3.0%
Q2 24
32.7%
-3.4%
Q1 24
34.4%
-2.9%
EPS (diluted)
DOCS
DOCS
LSAK
LSAK
Q4 25
$0.31
$0.04
Q3 25
$0.31
$-0.05
Q2 25
$0.27
$-0.40
Q1 25
$0.31
$-0.27
Q4 24
$0.37
$-0.40
Q3 24
$0.22
$-0.07
Q2 24
$0.21
$-0.08
Q1 24
$0.20
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCS
DOCS
LSAK
LSAK
Cash + ST InvestmentsLiquidity on hand
$64.8M
$69.5M
Total DebtLower is stronger
$216.8M
Stockholders' EquityBook value
$979.3M
$180.6M
Total Assets
$1.2B
$704.6M
Debt / EquityLower = less leverage
1.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCS
DOCS
LSAK
LSAK
Q4 25
$64.8M
$69.5M
Q3 25
$169.2M
$72.2M
Q2 25
$137.3M
$76.5M
Q1 25
$209.6M
$71.0M
Q4 24
$165.3M
$60.6M
Q3 24
$184.2M
$49.7M
Q2 24
$111.4M
$59.1M
Q1 24
$96.8M
$55.2M
Total Debt
DOCS
DOCS
LSAK
LSAK
Q4 25
$216.8M
Q3 25
$208.1M
Q2 25
$200.8M
Q1 25
$194.7M
Q4 24
$148.7M
Q3 24
$148.5M
Q2 24
$143.2M
Q1 24
$135.7M
Stockholders' Equity
DOCS
DOCS
LSAK
LSAK
Q4 25
$979.3M
$180.6M
Q3 25
$1.1B
$170.4M
Q2 25
$1.0B
$161.6M
Q1 25
$1.1B
$185.2M
Q4 24
$1.0B
$193.3M
Q3 24
$961.2M
$184.2M
Q2 24
$913.6M
$175.9M
Q1 24
$901.4M
$173.1M
Total Assets
DOCS
DOCS
LSAK
LSAK
Q4 25
$1.2B
$704.6M
Q3 25
$1.3B
$652.9M
Q2 25
$1.2B
$653.7M
Q1 25
$1.3B
$649.2M
Q4 24
$1.2B
$640.6M
Q3 24
$1.1B
$551.9M
Q2 24
$1.1B
$558.5M
Q1 24
$1.1B
$551.5M
Debt / Equity
DOCS
DOCS
LSAK
LSAK
Q4 25
1.20×
Q3 25
1.22×
Q2 25
1.24×
Q1 25
1.05×
Q4 24
0.77×
Q3 24
0.81×
Q2 24
0.81×
Q1 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCS
DOCS
LSAK
LSAK
Operating Cash FlowLast quarter
$60.9M
$-10.9M
Free Cash FlowOCF − Capex
$-14.8M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
0.99×
-2.99×
TTM Free Cash FlowTrailing 4 quarters
$-15.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCS
DOCS
LSAK
LSAK
Q4 25
$60.9M
$-10.9M
Q3 25
$93.9M
$8.9M
Q2 25
$62.1M
$-9.1M
Q1 25
$98.5M
$10.7M
Q4 24
$65.2M
$-9.2M
Q3 24
$68.3M
$-4.1M
Q2 24
$41.2M
$5.7M
Q1 24
$63.9M
$19.2M
Free Cash Flow
DOCS
DOCS
LSAK
LSAK
Q4 25
$-14.8M
Q3 25
$4.9M
Q2 25
$-13.2M
Q1 25
$7.8M
Q4 24
$-15.5M
Q3 24
$-8.1M
Q2 24
$937.0K
Q1 24
$16.2M
FCF Margin
DOCS
DOCS
LSAK
LSAK
Q4 25
-8.3%
Q3 25
2.9%
Q2 25
-7.8%
Q1 25
4.9%
Q4 24
-8.8%
Q3 24
-5.3%
Q2 24
0.6%
Q1 24
11.7%
Capex Intensity
DOCS
DOCS
LSAK
LSAK
Q4 25
2.2%
Q3 25
2.3%
Q2 25
2.4%
Q1 25
0.0%
1.7%
Q4 24
0.0%
3.6%
Q3 24
0.0%
2.6%
Q2 24
0.0%
3.2%
Q1 24
0.0%
2.1%
Cash Conversion
DOCS
DOCS
LSAK
LSAK
Q4 25
0.99×
-2.99×
Q3 25
1.51×
Q2 25
1.16×
Q1 25
1.58×
Q4 24
0.87×
Q3 24
1.55×
Q2 24
1.00×
Q1 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

LSAK
LSAK

Telecom Products And Services$82.0M46%
Processing Fees$37.6M21%
Enterprise Segment$14.5M8%
Rest Of Africa$10.9M6%
Technology Products$8.6M5%
Insurance Revenue$7.9M4%
Lending Revenue$7.2M4%
Other$6.7M4%
Interest From Customer$2.1M1%
Other Products And Services$1.2M1%

Related Comparisons